Literature DB >> 33553287

Fluids of the Future.

Thomas H Edwards1, Guillaume L Hoareau2.   

Abstract

Fluids are a vital tool in the armament of acute care clinicians in both civilian and military resuscitation. We now better understand complications from inappropriate resuscitation with currently available fluids; however, fluid resuscitation undeniably remains a life-saving intervention. Military research has driven the most significant advances in the field of fluid resuscitation and is currently leading the search for the fluids of the future. The veterinary community, much like our civilian human counterparts, should expect the fluid of the future to be the fruit of military research. The fluids of the future not only are expected to improve patient outcomes but also be field expedient. Those fluids should be compatible with military environments or natural disaster environments. For decades, military personnel and disaster responders have faced the peculiar demands of austere environments, prolonged field care, and delayed evacuation. Large scale natural disasters present field limitations often similar to those encountered in the battlefield. The fluids of the future should, therefore, have a long shelf-life, a small footprint, and be resistant to large temperature swings, for instance. Traumatic brain injury and hemorrhagic shock are the leading causes of preventable death for military casualties and a significant burden in civilian populations. The military and civilian health systems are focusing efforts on field-expedient fluids that will be specifically relevant for the management of those conditions. Fluids are expected to be compatible with blood products, increase oxygen-carrying capabilities, promote hemostasis, and be easy to administer in the prehospital setting, to match the broad spectrum of current acute care challenges, such as sepsis and severe systemic inflammation. This article will review historical military and civilian contributions to current resuscitation strategies, describe the expectations for the fluids of the future, and describe select ongoing research efforts with a review of current animal data.
Copyright © 2021 Edwards and Hoareau.

Entities:  

Keywords:  blood product development; hemorrhage; innovation; resuscitation; sepsis; shock; traumatic brain injury

Year:  2021        PMID: 33553287      PMCID: PMC7859481          DOI: 10.3389/fvets.2020.623227

Source DB:  PubMed          Journal:  Front Vet Sci        ISSN: 2297-1769


  73 in total

1.  Hemoglobin-based oxygen carriers: disclosed history and the way ahead: the relativity of safety.

Authors:  Richard B Weiskopf
Journal:  Anesth Analg       Date:  2014-10       Impact factor: 5.108

2.  Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood-brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion.

Authors:  D Douglas Powanda; Thomas M S Chang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2002-01

3.  Microvascular and Systemic Impact of Resuscitation with PEGylated Carboxyhemoglobin-Based Oxygen Carrier or Hetastarch in a Rat Model of Transient Hemorrhagic Shock.

Authors:  William H Nugent; Forest R Sheppard; Michael A Dubick; Ramon F Cestero; Daniel N Darlington; Ronald Jubin; Abe Abuchowski; Bjorn K Song
Journal:  Shock       Date:  2020-04       Impact factor: 3.454

4.  Detection of bacterial contamination and DNA quantification in stored blood units in 2 veterinary hospital blood banks.

Authors:  Valentina Stefanetti; Arianna Miglio; Katia Cappelli; Stefano Capomaccio; Elisa Sgariglia; Maria L Marenzoni; Maria T Antognoni; Mauro Coletti; Vittorio Mangili; Fabrizio Passamonti
Journal:  Vet Clin Pathol       Date:  2016-07-11       Impact factor: 1.180

Review 5.  Bio-inspired nanomedicine strategies for artificial blood components.

Authors:  Anirban Sen Gupta
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-15

Review 6.  Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia.

Authors:  Bryan D Hux; Linda G Martin
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2012-02

7.  Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study.

Authors:  Robert Goggs; Signe Cremer; Marjory B Brooks
Journal:  Vet Rec Open       Date:  2020-08-07

8.  Adenosine, lidocaine, and Mg2+ (ALM) resuscitation fluid protects against experimental traumatic brain injury.

Authors:  Hayley L Letson; Geoffrey P Dobson
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

9.  Biological evaluation of liposome-encapsulated hemoglobin surface-modified with a novel PEGylated nonphospholipid amphiphile.

Authors:  Vivek R Yadav; Okhil Nag; Vibhudutta Awasthi
Journal:  Artif Organs       Date:  2014-04-22       Impact factor: 3.094

10.  Efficacy of the perfluorocarbon dodecafluoropentane as an adjunct to pre-hospital resuscitation.

Authors:  Alicia M Bonanno; Todd L Graham; Lauren N Wilson; Brianne M Madtson; James D Ross
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.